2023 Full Event Guide

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!

If you are interested in the 2024 event, please get in touch at info@hansonwade.com

 

Take a look at the upcoming Gene Therapy Meetings 

Some of 2023's Hottest Sessions:

  • Participate in a deep dive discussion on how to set up your clinical trial design to please regulators with an ex-FDA reviewer and current Director of Regulatory Affairs at REGENXBIO as the company prepares for BLA application of their gene therapy 
  • Join AbbVie to hear about the current landscape of rodent and primate brain tropic Capsid design, where you will see exciting data benchmarked against AAV9 and AAV PHP.B.  
  • Hear from the Allen Institute on how to compare the biodistribution of different vectors in macaque models following the ICV route of administration, and hear the latest data from a head-to-head comparison of two leading viral vectors 
  • Learn case study-led insights from Maze Therapeutics on progressing their nonclinical gene therapy program for ALS and how they plan to progress into the clinic 

Get in touch to find more information about the agenda and how you can benefit from joining the 5th Gene Therapy for Neurological Disorders 2023.

Gene Therapy For Neuro

Having issues downloading? Click here

Speakers on the 2023 Program Included:

Anindya Sen Headshot

Anindya Sen

Executive Director, Research & Development

Eli Lilly & Co.

Dunni Odumosu Headshot

Dunni Odumosu

Vice President of Global Regulatory Affairs

Bridge Bioscience Corp

Fergus Quigley Headshot

Fergus Quigley

Director, Early Stage Development Leader

Takeda Pharmaceutical Co. Ltd.

Matt Kelley Headshot

Matt Kelley

Senior Scientist, Rare Disease

Pfizer

Mengying Zhang Headshot

Mengying Zhang

Scientist

Biogen

Shyam Ramachandran Headshot

Shyam Ramachandran

Neuroscience Head, Genomic Medicines Unit

Sanofi